Erzsébet Csányi

Dr. Erzsébet Csányi

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 August 2019 in Scientia Pharmaceutica
Verified
Journal Article
Open access
PDF file
SZStella Zsikó
Stella Zsikó
ECErzsébet Csányi
Erzsébet Csányi
AKAnita Kovacs
Anita Kovacs
MBMária Budai-Szűcs
Mária Budai-Szűcs
AGAttila Gácsi
Attila Gácsi
SBSzilvia Berkó
Szilvia Berkó
Dermal and transdermal drug therapy is increasing in importance nowadays in drug development. To completely utilize the potential of this administration route, it is necessary to optimize the drug release and skin penetration measurements. This review covers the most well-known and up-to-date methods for evaluating the cutaneous penetration of drugs in vitro as a supporting tool for pharmaceutical research scientists in the early stage of drug development. The aim of this article is to present various experimental models used in dermal/transdermal research and summarize the novel knowledge about the main in vitro methods available to study skin penetration. These techniques are: Diffusion cell, skin-PAMPA, tape stripping, two-photon microscopy, confocal laser scanning microscopy, and confocal Raman microscopic method.

1 January 2015 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
GHGabriella Horvát
Gabriella Horvát
BGBenjámin Gyarmati
Benjámin Gyarmati
SBSzilvia Berkó
Szilvia Berkó
PSPiroska Szabó-Révész
Piroska Szabó-Révész
BSBarnabás Áron Szilágyi
Barnabás Áron Szilágyi
MBMária Budai-Szűcs
Mária Budai-Szűcs

1 March 2017 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
AKAnita Kovacs
Anita Kovacs
SBSz. Berkó
Sz. Berkó
ECErzsébet Csányi
Erzsébet Csányi
Ildikó CsókaIldikó Csóka
Ildikó Csóka

14 December 2019 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
EKEszter L. Kiss
Eszter L. Kiss
SBSzilvia Berkó
Szilvia Berkó
AGAttila Gácsi
Attila Gácsi
AKAnita Kovacs
Anita Kovacs
GKGábor Katona
Gábor Katona
MBMária Budai-Szűcs
Mária Budai-Szűcs
The aim of this study was to perform a preformulation study of dexamethasone (DXM)-loaded nanostructured lipid carriers (NLCs) for ocular use. Lipid screening was applied to find the most suitable solid and liquid lipids and surfactant for the NLC formulation. The visual observation was proved with XRD measurements for the establishment of the soluble state of DXM. Thermoanalytical measurements indicated that the most relevant depression of the crystallinity index could be ensured when using a 7:3 solid lipid:oil ratio. In order to optimize the NLC composition, a 23 full factorial experimental design was used. It was established that each independent factor (lipid, DXM, and surfactant concentration) had a significant effect on the particle size while in the case of entrapment efficiency, the DXM and surfactant concentrations were significant. Lower surfactant and lipid concentrations could be beneficial because the stability and the entrapment efficacy of NLCs were more favorable. The toxicity tests on human cornea cells indicated good ophthalmic tolerability of NLCs. The in vitro drug release study predicted a higher concentration of the solute DXM on the eye surface while the Raman mapping penetration study on the porcine cornea showed a high concentration of nanocarriers in the hydrophylic stroma layer.

1 October 2016 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
COCamelia Oprean
Camelia Oprean
MMMarius Mioc
Marius Mioc
ECErzsébet Csányi
Erzsébet Csányi
RARita Ambrus
Rita Ambrus
FBFlorina Bojin
Florina Bojin
Codruta SoicaCodruta Soica
Codruta Soica

2 July 2019 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
SZStella Zsikó
Stella Zsikó
KCKendra Cutcher
Kendra Cutcher
AKAnita Kovacs
Anita Kovacs
MBMária Budai-Szűcs
Mária Budai-Szűcs
AGAttila Gácsi
Attila Gácsi
SBSzilvia Berkó
Szilvia Berkó
The aim of this research was to investigate the stability of a lidocaine-loaded nanostructured lipid carrier dispersion at different temperatures, formulate a nanostructured lipid carrier gel, and test the penetration profile of lidocaine from the nanostructured lipid carrier gel using different skin penetration modeling methods. The formulations were characterized by laser diffraction, rheological measurements and microscopic examinations. Various in vitro methods were used to study drug release, diffusion and penetration. Two types of vertical Franz diffusion cells with three different membranes, including cellulose, Strat-M®, and heat separated human epidermis were used and compared to the Skin-parallel artificial membrane permeability assay (PAMPA) method. Results indicated that the nanostructured lipid carrier dispersion had to be gelified as soon as possible for proper stability. Both the Skin-PAMPA model and Strat-M® membranes correlated favorably with heat separated human epidermis in this research, with the Strat-M® membranes sharing the most similar drug permeability profile to an ex vivo human skin model. Our experimental findings suggest that even when the best available in vitro experiment is selected for modeling human skin penetration to study nanostructured lipid carrier gel systems, relevant in vitro/in vivo correlation should be made to calculate the drug release/permeation in vivo. Future investigations in this field are still needed to demonstrate the influence of membranes and equipment from other classes on other drug candidates.